Navigation Links
LifeBotanica's Groundbreaking Anti-Aging Supplement, AGE DEFYING, Introduced
Date:6/11/2013

Long Island, NY (PRWEB) June 11, 2013

LifeBotanica is proud to announce the launch of their new revolutionary anti-aging supplement, AGE DEFYING. The innovative anti-aging supplement embodies LifeBotanica’s belief in healthy aging through genetic nutrition. Using scientifically tested antioxidants, AGE DEFYING targets the biological causes of aging by combating oxidation, making it the first supplement of its kind on the market.

“Incredible amounts of time and research have gone into the ingredients in AGE DEFYING,” stated LifeBotanica’s founder Petronely Grindea. “The product really embraces the LifeBotanica’s belief of combating the aging process through genetic nutrition.”

AGE DEFYING, set to debut in the United States in June 2013, was the result of a joint effort between LifeBotanica and distinguished skin care scientists such as Dr. Sultana Hague. The supplement will feature various antioxidants that will not only help reverse signs of aging, but it will slow the aging process on a biological level. ResVinol™, a key antioxidant in AGE DEFYING, promotes the slowing of the aging process through the stimulation of the SIRT1 gene. Other significant antioxidants, such as Grape Seed Extract and Setria™, help prevent further cell damage by protecting cell membranes from oxidative damage, stopping free radicals in their tracks, and promote anti-aging through reversing the damage that causes wrinkles.

LifeBotanica has a full line of products that are aimed to detoxify the body by eliminating harmful environmental and dietary toxins and promoting regularity and weight loss. With more and more of the population turning to alternative holistic remedies, natural products and body detoxification, LifeBotanica and its all natural detox products have created quite a buzz on the social media sites such as Facebook and Twitter.

Petronely stated, “LifeBotanica believes in detoxifying the body through the use of organic, herbal products. We work hard to create products that will provide our customers with a greater quality of life.”

Industry leader Petronely Grindea has over 20 years of experience in the Health and Wellness industry and has worked with industry giants Estée Lauder and Elizabeth Arden. Bringing her wealth of knowledge to LifeBotanica, Petronely has made a commitment to provide the market with supplements that aid in natural life extension and now bringing AGE DEFYING into the market as an anti-aging supplement to aid in the fight against aging and the journey to better health.

ABOUT LifeBotanica
LifeBotanica is a complete life changing detoxification program based on a 200-year-old European Botanical Formula that has improved and enriched the lives of many. LifeBotanica truly embodies the realization that holistic healing is an essential component of wellness. For more information follow LifeBotanica on Facebook and Twitter.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10820774.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Living Well Medical Introduces Groundbreaking Non-Surgical Therapies for Osteoarthritis Knee Pain
2. Intermountain Vein Center Announces Groundbreaking Guidelines in Treatment of Acute Ischemic Stroke
3. West Penn Allegheny Health System is First in Pennsylvania to Perform Groundbreaking Minimally-Invasive Procedure for Swallowing Disorder
4. Groundbreaking study to transform service users involvement in mental health care
5. Groundbreaking UK study shows key enzyme missing from aggressive form of breast cancer
6. Groundbreaking Training Video Prepares Surgical Team to Become Safest in the U.S.
7. Skin Authority Creates One-of-a-Kind Solution for the One Billion People Worldwide Who are Vitamin D Deficient -- Groundbreaking Launch of "Inside Out" System
8. Rectal microbicide research takes giant leap forward with groundbreaking educational video
9. MyPuress Releases Details About Groundbreaking New Product
10. JTCC researchers play important role in groundbreaking study that may change transplant practices
11. FEMA awards $1 Million to WPI to develop groundbreaking toxic gas sensors for firefighters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... , ... May 24, 2017 , ... ... of ExtraHop to its solutions portfolio. ExtraHop delivers an analytics-first approach, layered with ... every IT system, from the datacenter to the cloud to the edge. Through ...
(Date:5/24/2017)... ... 24, 2017 , ... The CFOs included on this list ... in the nation and help their organizations navigate the challenges in healthcare today. ... in developing successful hospital and health system strategy. , Becker's Hospital Review has ...
(Date:5/23/2017)... ... May 23, 2017 , ... MDLand International (MDLand), a ... today that its iClinic V12.2 solution has achieved approval from National Center for ... PCMH 2017 standards which emphasize team-based care with a significant focus on the ...
(Date:5/23/2017)... ... May 23, 2017 , ... Cambridge, MA, May ... since 2009, according to a Workers Compensation Research Institute (WCRI) study, a contrast ... North Carolina System: CompScope™ Benchmarks, 17th Edition looks at indemnity and medical ...
(Date:5/23/2017)... ... 2017 , ... London, May 23, 2017: Walter Schindler, the Founder and Managing ... Guest Speaker and Contributor to a weeklong series of classes, meetings, field trips and ... , Walter Schindler and SAIL Capital have received an increasing number ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)... -- Bayer announced today that the latest research from across ... 53 rd Annual Meeting of the American Society ... Chicago . The ... and thyroid cancers, as well as lymphomas, and includes ... of copanlisib in patients with relapsed or refractory follicular ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: